Geode Capital Management
KRTX

Geode Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Geode Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-569,722
Closed -$180M – 4662
2023
Q4 		$180M Buy
569,722
+24,649
+5% +$4.79M 0.02% 584
2023
Q3 		$92.2M Buy
545,073
+60,926
+13% +$11.5M 0.01% 837
2023
Q2 		$105M Sell
484,147
-118,288
-20% -$25.3M 0.01% 769
2023
Q1 		$109M Buy
602,435
+65,948
+12% +$12.6M 0.01% 703
2022
Q4 		$105M Buy
536,487
+30,636
+6% +$6.57M 0.01% 700
2022
Q3 		$114M Buy
505,851
+81,451
+19% +$16.5M 0.02% 637
2022
Q2 		$53.7M Buy
424,400
+26,525
+7% +$3.05M 0.01% 1060
2022
Q1 		$50.4M Buy
397,875
+9,997
+3% +$1.13M 0.01% 1246
2021
Q4 		$50.8M Buy
387,878
+19,523
+5% +$2.52M 0.01% 1302
2021
Q3 		$45.1M Buy
368,355
+9,384
+3% +$1.08M 0.01% 1371
2021
Q2 		$40.9M Buy
358,971
+64,233
+22% +$7.51M 0.01% 1485
2021
Q1 		$35.4M Buy
294,738
+38,941
+15% +$4.41M 0.01% 1488
2020
Q4 		$26M Buy
255,797
+7,091
+3% +$657K ﹤0.01% 1550
2020
Q3 		$19.2M Buy
248,706
+43,423
+21% +$3.7M ﹤0.01% 1564
2020
Q2 		$22.9M Buy
205,283
+35,063
+21% +$3.05M ﹤0.01% 1420
2020
Q1 		$12.3M Buy
170,220
+81,418
+92% +$6.96M ﹤0.01% 1613
2019
Q4 		$6.69M Buy
88,802
+19,050
+27% +$834K ﹤0.01% 2277
2019
Q3 		$1.14M Buy
+69,752
New +$1.36M ﹤0.01% 3183

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Geode Capital Management's KRTX Position: Q1 2024 in Review

Geode Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 569,722 shares — an estimated $180M sold.

Geode Capital Management first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $180M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Geode Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 569,722 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $180M.
  • Geode Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
  • Geode Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $180M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.